Biophytis SA (FR:ALBPS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biophytis SA is set to participate in the 17th SCWD Congress and host an Obesity Investor Call exploring the muscle loss associated with GLP-1 RA obesity treatments. The event will feature discussions led by prominent experts in the field and highlight Biophytis’ strategic positioning in addressing these side effects. This engagement underscores Biophytis’ commitment to advancing solutions for age-related diseases and strengthening its presence in the biotech market.
For further insights into FR:ALBPS stock, check out TipRanks’ Stock Analysis page.